NeuroVigil Inc. Announces Landmark Autism Collaboration

LA JOLLA, Calif. & PALO ALTO, Calif.--(BUSINESS WIRE)--NeuroVigil, Inc., a leading California-based neurotechnology company, will collaborate with investigators at Stanford University on a two-year study of sleep disorders and neural architecture mapping of individuals with Autism Spectrum Disorder. On the Stanford side, the study will be headed by Dr. Ruth O’Hara at the prestigious Stanford University School of Medicine.